rs58747567

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001080.3(ALDH5A1):​c.1389T>C​(p.Asp463Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00928 in 1,613,906 control chromosomes in the GnomAD database, including 106 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0068 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0095 ( 100 hom. )

Consequence

ALDH5A1
NM_001080.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.74

Publications

9 publications found
Variant links:
Genes affected
ALDH5A1 (HGNC:408): (aldehyde dehydrogenase 5 family member A1) This protein belongs to the aldehyde dehydrogenase family of proteins. This gene encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. A deficiency of this enzyme, known as 4-hydroxybutyricaciduria, is a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA). In response to the defect, physiologic fluids from patients accumulate GHB, a compound with numerous neuromodulatory properties. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
ALDH5A1 Gene-Disease associations (from GenCC):
  • succinic semialdehyde dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-24532164-T-C is Benign according to our data. Variant chr6-24532164-T-C is described in ClinVar as [Benign]. Clinvar id is 287826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.74 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00681 (1037/152322) while in subpopulation NFE AF = 0.0117 (796/68018). AF 95% confidence interval is 0.011. There are 6 homozygotes in GnomAd4. There are 468 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH5A1NM_001080.3 linkc.1389T>C p.Asp463Asp synonymous_variant Exon 9 of 10 ENST00000357578.8 NP_001071.1 P51649-1X5DQN2
ALDH5A1NM_170740.1 linkc.1428T>C p.Asp476Asp synonymous_variant Exon 10 of 11 NP_733936.1 P51649-2X5D299
ALDH5A1NM_001368954.1 linkc.1245T>C p.Asp415Asp synonymous_variant Exon 8 of 9 NP_001355883.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH5A1ENST00000357578.8 linkc.1389T>C p.Asp463Asp synonymous_variant Exon 9 of 10 1 NM_001080.3 ENSP00000350191.3 P51649-1

Frequencies

GnomAD3 genomes
AF:
0.00681
AC:
1037
AN:
152204
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00616
AC:
1549
AN:
251444
AF XY:
0.00623
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.00382
Gnomad ASJ exome
AF:
0.00327
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00166
Gnomad NFE exome
AF:
0.0110
Gnomad OTH exome
AF:
0.00423
GnomAD4 exome
AF:
0.00954
AC:
13938
AN:
1461584
Hom.:
100
Cov.:
30
AF XY:
0.00932
AC XY:
6774
AN XY:
727112
show subpopulations
African (AFR)
AF:
0.00161
AC:
54
AN:
33480
American (AMR)
AF:
0.00423
AC:
189
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00306
AC:
80
AN:
26136
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39696
South Asian (SAS)
AF:
0.00117
AC:
101
AN:
86256
European-Finnish (FIN)
AF:
0.00197
AC:
105
AN:
53414
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0116
AC:
12912
AN:
1111726
Other (OTH)
AF:
0.00805
AC:
486
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
730
1460
2191
2921
3651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00681
AC:
1037
AN:
152322
Hom.:
6
Cov.:
33
AF XY:
0.00628
AC XY:
468
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00221
AC:
92
AN:
41582
American (AMR)
AF:
0.00595
AC:
91
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5190
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
796
AN:
68018
Other (OTH)
AF:
0.0118
AC:
25
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00908
Hom.:
4
Bravo
AF:
0.00732
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0108
EpiControl
AF:
0.0108

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ALDH5A1: BP4, BP7, BS1, BS2 -

Aug 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Succinate-semialdehyde dehydrogenase deficiency Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 03, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.086
DANN
Benign
0.32
PhyloP100
-3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58747567; hg19: chr6-24532392; COSMIC: COSV62373265; API